🇺🇸 FDA
Patent

US 8999987

Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)

granted A61KA61K31/282A61K31/4745

Quick answer

US patent 8999987 (Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOMARIN PHARMACEUTICAL INC.
Grant date
Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/282, A61K31/4745, A61K31/495, A61K31/5025